Real-World Data / Real-Word Evidence Resources

51. Why Research Sites Don't Use EMR As The Source Data Collection Tool 9/21/2022

    Examine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.

52. 8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development 2/3/2025

    Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.

53. One Day, Clinical Trials Will Represent The Real World 2/12/2024

    What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.

54. Overcoming Issues Of Non-Enrolling Sites In Clinical Trials 1/14/2025

    Explore the challenges of non-enrolling sites in clinical trials, focusing on the benefits of leveraging artificial intelligence (AI) and machine learning (ML) in addressing those issues.

55. Understanding The Perceptions And Potential Of Clinical Research 4/14/2025

    The PA Consulting Clinical Trials Pulse Report 2024 presents a compelling picture of public perceptions, challenges, and innovation opportunities in clinical trial design and delivery.

56. Using RWE To Get To Insights And Action — Faster 11/17/2023

    Delve into three examples that vividly showcase the formidable power of real-world evidence from the early stages of drug development through clinical trials and commercialization.

57. Unlocking The Power Of Real-World Evidence In FDA Submissions 5/15/2023

    Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.

58. The Hidden Cost Of Preferred Vendors 10/21/2025

    Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.

59. Single-Arm Trials Use Real-World Evidence For Rare Disease Drug Development 3/1/2022

    In rare disease product development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Gain insight into the regulatory considerations for single-arm trials.

60. CDW: An Evolving Product Category Speeds Access To Quality Data 6/21/2024

    Explore how exponential increases in third-party patient data have catalyzed the emergence of the clinical data workbench, representing a pivotal advancement in the evolving field of data management.